•
Sep 30, 2020

Voyager Therapeutics Q3 2020 Earnings Report

Total Revenue
$118M
Previous year: $20.4M
+476.7%
EPS
$2.27
Previous year: -$0.41
-653.7%
Gross Profit
$92.8M
Previous year: -$9.34M
-1093.2%
Cash and Equivalents
$147M
Previous year: $82.6M
+78.4%
Free Cash Flow
-$29.9M
Previous year: -$22.8M
+31.4%
Total Assets
$270M
Previous year: $376M
-28.3%

Voyager Therapeutics

Voyager Therapeutics

Voyager Therapeutics Revenue by Segment